Global Blood Screening Market

Blood Screening Market Size, Share & Trends Analysis Report, By Product (Instruments, Reagents & Kits, Software & Services), By End User (Hospitals, Blood Banks), By Technology, By Region, And Industry Forecast, 2026-2033

Report ID: SQMIG35D2344 | Region: Global | Published Date: August, 2025
Pages: 182 |Tables: 91 |Figures: 73

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Blood Screening Market size was valued at USD 3.61 Billion in 2024 and is poised to grow from USD 4 Billion in 2025 to USD 9.16 Billion by 2033, growing at a CAGR of 10.9% during the forecast period (2026–2033).

    Blood screening providers should focus on raising more awareness regarding the importance of blood donations and transfusions to maximize their sales potential. Investing in the R&D of novel portable and rapid blood screening solutions is also a key opportunity for companies as per this global blood screening market analysis. 'Abbott Laboratories (USA)', 'Becton, Dickinson and Company (USA)', 'Bio-Rad Laboratories, Inc. (USA)', 'bioMerieux SA (France)', 'F. Hoffmann-La Roche Ltd. (Switzerland)', 'Grifols, S.A. (Spain)', 'Hologic, Inc. (USA)', 'Quotient Limited (UK)', 'Siemens Healthineers AG (Germany)', 'Sysmex Corporation (Japan)', 'Thermo Fisher Scientific Inc. (USA)', 'Danaher Corporation (USA)', 'Grifols Diagnostic Solutions Inc. (USA)', 'Haemonetics Corporation (USA)', 'Natera, Inc. (USA)', 'Novartis International AG (Switzerland)', 'Promega Corporation (USA)'

    Governments, NGOs, and health organizations are playing a crucial role in promoting awareness regarding the importance of safe blood donation practices. Blood banks and hospitals are investing in better donor screening and implementing pre-donation tests to maintain quality standards. This rising awareness improves donor trust and participation, while also encouraging adoption of more sophisticated testing methods to ensure blood safety and public health.

    Shift Toward Multiplex and Molecular Testing: Healthcare professionals are opting multiplex and molecular diagnostic technologies due to their ability to detect multiple pathogens in a single test. Need for identification of co-infections like HIV, HBV, and HCV simultaneously is expected to help bolster the importance of this blood screening industry trend. These technologies enable efficient and accurate pathogen detection, especially in areas with high transfusion volumes.

    Why is Adoption of Blood Screening High in North America?

    Related Reports

    Blood Testing Market
    Buy Now GET FREE SAMPLE
    Drug Screening Market
    Buy Now GET FREE SAMPLE
    Cellular Health Screening Market
    Buy Now GET FREE SAMPLE
    Patient Blood Management Market
    Buy Now GET FREE SAMPLE
    Hematology Analyzer Market
    Buy Now GET FREE SAMPLE
    Hematology Diagnostics Market
    Buy Now GET FREE SAMPLE
    HERG Screening Market
    Buy Now GET FREE SAMPLE
    Blood Collection Tubes Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Blood Screening Market

    Report ID: SQMIG35D2344

    $5,300
    BUY NOW